COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.
Blood Adv
; 6(7): 2427-2433, 2022 04 12.
Article
in En
| MEDLINE
| ID: mdl-34749396
Full text:
1
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2022
Type:
Article
Affiliation country:
Italy